![Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial | Stroke Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial | Stroke](https://www.ahajournals.org/cms/asset/1f6fecc0-4832-4f20-af2f-06a56a5093dc/strokeaha.121.037548.fig01.jpg)
Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial | Stroke
![Conductance Artery Wall Layers and Their Respective Roles in the Clearance Functions | Arteriosclerosis, Thrombosis, and Vascular Biology Conductance Artery Wall Layers and Their Respective Roles in the Clearance Functions | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b8b38f31-deb2-4613-ac56-6e371b99e365/atvbaha.122.317759.fig06.jpg)
Conductance Artery Wall Layers and Their Respective Roles in the Clearance Functions | Arteriosclerosis, Thrombosis, and Vascular Biology
![A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy - Zelek - 2021 - The Oncologist - Wiley Online Library A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy - Zelek - 2021 - The Oncologist - Wiley Online Library](https://theoncologist.onlinelibrary.wiley.com/cms/asset/d8a823e3-3cad-4d17-8c31-d9ce1963d04a/onco13888-fig-0001-m.jpg)
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy - Zelek - 2021 - The Oncologist - Wiley Online Library
![PDF) Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: Focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort PDF) Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: Focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort](https://i1.rgstatic.net/publication/281846854_Evaluation_in_usual_practice_of_the_bevacizumab-FOLFIRI_combination_for_the_first-line_treatment_of_patients_with_unresectable_metastatic_colorectal_cancer_treated_in_2006_Focus_on_resected_patients_a/links/569bc22508ae748dfb102c9b/largepreview.png)